Credit Suisse Ag Cyma Bay Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$12.63 - $24.47 $137,831 - $267,041	-10,913 Reduced 6.75%	150,752 $3.56 Million
Q3 2023 Nov 13, 2023	SELL	$10.86 - $17.62 $112,857 - $183,107	-10,392 Reduced 6.04%	161,665 $2.41 Million
Q2 2023 Aug 11, 2023	BUY	$7.47 - $10.95 $794,143 - $1.16 Million	106,311 Added 161.7%	172,057 $1.88 Million
Q1 2023 May 10, 2023	BUY	$5.88 - $9.59 $386,586 - $630,504	65,746 New	65,746 $573,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $4.92 $138,959 - $173,523	-35,269 Closed	0 $0

Q1 2021 May 14, 2021	SELL	$4.23 - $6.55 $17,753 - $27,490	-4,197 Reduced 10.63%	35,269 $160,000
Q4 2020 Feb 12, 2021	BUY	$5.73 - $9.03 $226,140 - $356,377	39,466 New	39,466 $226,000
Q3 2020 Nov 13, 2020	SELL	$3.32 - $7.24 $1.63 Million - $3.55 Million	-490,223 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$1.41 - $4.25 $172,114 - $518,784	-122,067 Reduced 19.94%	490,223 $1.71 Million
Q1 2020 May 13, 2020	BUY	$1.25 - $2.02 $720,976 - $1.17 Million	576,781 Added 1624.32%	612,290 $907,000
Q4 2019 Feb 12, 2020	SELL	$1.33 - $5.93 $14,743 - $65,734	-11,085 Reduced 23.79%	35,509 $70,000
Q3 2019 Nov 12, 2019	BUY	$5.12 - $7.21 $15,385 - $21,666	3,005 Added 6.89%	46,594 $238,000
Q2 2019 Aug 14, 2019	SELL	$6.05 - $13.66 $4.76 Million - $10.7 Million	-786,518 Reduced 94.75%	43,589 $311,000
Q1 2019 May 14, 2019	BUY	$8.16 - $13.42 $6.44 Million - $10.6 Million	789,594 Added 1948.99%	830,107 $11 Million
Q4 2018 Feb 13, 2019	SELL	$6.54 - $11.74 $2,812 - $5,048	-430 Reduced 1.05%	40,513 $319,000
Q3 2018 Nov 13, 2018	SELL	$10.88 - $14.52 $187,233 - $249,874	-17,209 Reduced 29.59%	40,943 $453,000
Q2 2018 Aug 14, 2018	BUY	$10.66 - $14.38 $390,827 - $527,213	36,663 Added 170.61%	58,152 $780,000
Q1 2018 May 15, 2018	SELL	$9.0 - $15.16 $71,514 - $120,461	-7,946 Reduced 27.0%	21,489 $279,000
Q4 2017 Feb 14, 2018	BUY	$7.67 - $9.31 $104,258 - $126,550	13,593 Added 85.8%	29,435 $271,000
Q3 2017 Nov 14, 2017	BUY	$5.95 - $8.26 $94,259 - $130,854	15,842	15,842 $127,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.88M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account